Literature DB >> 9701467

Expression and distribution of transforming growth factor-beta isoforms and their signaling receptors in growing human bone.

A Horner1, P Kemp, C Summers, S Bord, N J Bishop, A W Kelsall, N Coleman, J E Compston.   

Abstract

Transforming growth factors type beta (TGF-beta1, -beta2, and -beta3) are potent stimulators of bone formation and have been shown to regulate chondrocyte, osteoblast, and osteoclast formation and function. However, the distribution of the different isoforms and their signaling receptors in human bone in vivo has not previously been reported. Using samples of normal (neonatal rib) and pathological (osteophytic) developing human bone, we have investigated the expression of the different TGF-beta isoforms and their signaling receptors (TGF-betaRI and RII) at the messenger ribonucleic acid (mRNA) and protein levels by in situ hybridization and immunolocalization to establish the sites of TGF-beta production and their possible sites of action during human bone development in vivo. All three TGF-beta isoforms and the receptors were detected at sites of endochondral and intramembranous ossification. At sites of endochondral ossification, TGF-beta2 was detected in all zones of the cartilage, with the highest expression seen in the hypertrophic and mineralizing zones. TGF-beta3 was detected in proliferative and hypertrophic zone chondrocytes, while TGF-beta1 expression was restricted to the proliferative and upper hypertrophic zones. TGF-betaRI and RII exhibited similar distributions with maximum expression in the hypertrophic and mineralizing zones in the neonatal rib but in the resting/proliferative zone in the developing osteophyte. At sites of intramembranous ossification TGF-beta3 was the most widely distributed isoform and showed both matrix- and cell-associated staining. TGF-beta2 and -beta1 were expressed almost exclusively at sites of mineralization. These observations demonstrate that the different TGF-beta isoforms and their receptors exhibit distinct but overlapping patterns of expression, and support the hypothesis that they are involved in the regulation of endochondral and intramembranous ossification during human bone development in vivo.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9701467     DOI: 10.1016/s8756-3282(98)00080-5

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  30 in total

1.  Autologous Osteophyte Grafting for Open-Wedge High Tibial Osteotomy.

Authors:  Takenori Akiyama; Ken Okazaki; Taro Mawatari; Satoshi Ikemura; Shunsuke Nakamura
Journal:  Arthrosc Tech       Date:  2016-09-05

2.  Expression of transforming growth factor-beta isoforms and their receptors in chronic tendinosis.

Authors:  S A Fenwick; V Curry; R L Harrall; B L Hazleman; R Hackney; G P Riley
Journal:  J Anat       Date:  2001-09       Impact factor: 2.610

Review 3.  Therapeutic targeting of the prostate cancer microenvironment.

Authors:  Maria Karlou; Vassiliki Tzelepi; Eleni Efstathiou
Journal:  Nat Rev Urol       Date:  2010-09       Impact factor: 14.432

4.  Immunolocalisation of vascular endothelial growth factor (VEGF) in human neonatal growth plate cartilage.

Authors:  A Horner; N J Bishop; S Bord; C Beeton; A W Kelsall; N Coleman; J E Compston
Journal:  J Anat       Date:  1999-05       Impact factor: 2.610

Review 5.  TGFβ signaling in cartilage development and maintenance.

Authors:  Weiguang Wang; Diana Rigueur; Karen M Lyons
Journal:  Birth Defects Res C Embryo Today       Date:  2014-03

Review 6.  TGF-beta signaling in chondrocytes.

Authors:  Tian-Fang Li; Regis J O'Keefe; Di Chen
Journal:  Front Biosci       Date:  2005-01-01

7.  Transforming growth factor-beta2 suppresses collagen cleavage in cultured human osteoarthritic cartilage, reduces expression of genes associated with chondrocyte hypertrophy and degradation, and increases prostaglandin E(2) production.

Authors:  Elena V Tchetina; John Antoniou; Michael Tanzer; David J Zukor; A Robin Poole
Journal:  Am J Pathol       Date:  2006-01       Impact factor: 4.307

8.  Regulation of immature cartilage growth by IGF-I, TGF-beta1, BMP-7, and PDGF-AB: role of metabolic balance between fixed charge and collagen network.

Authors:  Anna Asanbaeva; Koichi Masuda; Eugene J-M A Thonar; Stephen M Klisch; Robert L Sah
Journal:  Biomech Model Mechanobiol       Date:  2007-08-29

9.  Bone-Induced Expression of Integrin β3 Enables Targeted Nanotherapy of Breast Cancer Metastases.

Authors:  Michael H Ross; Alison K Esser; Gregory C Fox; Anne H Schmieder; Xiaoxia Yang; Grace Hu; Dipanjan Pan; Xinming Su; Yalin Xu; Deborah V Novack; Thomas Walsh; Graham A Colditz; Gabriel H Lukaszewicz; Elizabeth Cordell; Joshua Novack; James A J Fitzpatrick; David L Waning; Khalid S Mohammad; Theresa A Guise; Gregory M Lanza; Katherine N Weilbaecher
Journal:  Cancer Res       Date:  2017-08-30       Impact factor: 12.701

10.  Critical roles of the TGF-beta type I receptor ALK5 in perichondrial formation and function, cartilage integrity, and osteoblast differentiation during growth plate development.

Authors:  Tomoya Matsunobu; Kiyoyuki Torigoe; Masaki Ishikawa; Susana de Vega; Ashok B Kulkarni; Yukihide Iwamoto; Yoshihiko Yamada
Journal:  Dev Biol       Date:  2009-06-06       Impact factor: 3.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.